Drug Approval & Reimbursement in 2025

• Japan Approves Moderna RSV Vaccine, GSK’s ADC, and More
  May 20, 2025

• Chuikyo OKs Listing of Tevimbra, Camzyos, Tremfya, and More
  May 15, 2025

• Chugai’s DMD Gene Therapy Snags Conditional Approval in Japan
  May 14, 2025

• J-TEC’s JACC Widens Label into Knee Osteoarthritis
  May 14, 2025

• Japan Approves Spikevax’s Prefilled Syringe Version
  April 24, 2025

• Amgen’s Imdelltra, CSL’s Andembry to Join NHI Price List on April 16
  April 10, 2025

• Japan Approves Tablet Form of Chugai’s SMA Med Evrysdi
  March 31, 2025

• Japan Approves J&J’s Lazcluze, Genmab’s Tivdak, and More
  March 28, 2025

• Japan Approves Tablet Forms of Sleep Aid Melatobel: Nobelpharma
  March 18, 2025

• Zepbound, Qalsody, and More New Drugs Set for Japan Listing on March 19
  March 13, 2025

• Japan Approves CSL’s HAE Med Andembry, Tecentriq Sarcoma Use, and More
  February 21, 2025

• CureApp’s Alcoholism Therapy App Approved in Japan
  February 19, 2025

• Japan Approves Shionogi’s Therapy App for Pediatric ADHD
  February 19, 2025

• Espha’s Januvia Generic on Approval Roster towards June Listing
  February 18, 2025

• UCB Bags Japan Approval for Bimzelx’s 320 mg Auto-Injector
  February 7, 2025

ページ